{"course":{"id":"11421GP01001","name":"組織工程","enroll_type":"選修","general_type":"","dept":"生醫暨醫材博士學程","grade":1,"class_group":"甲","teacher":"劉昭麟","credit":3,"hour":3,"time":[{"day":2,"section":[5,6,7]}],"classroom":"","max":20,"min":2,"remark":"English-taught course","alt_for":"","courses":""},"detail":[["指定教材","Primary Textbooks:\n• Lanza, Langer, & Vacanti — Principles of Tissue Engineering (5th Edition)\n• Atala & Yoo — Essentials of Regenerative Medicine\n• Palsson & Bhatia — Tissue Engineering"],["參考教材","Recommended Journals:\n• Biomaterials\n• Tissue Engineering Part A/B/C\n• Advanced Healthcare Materials\n• Nature Communications (Regenerative Medicine)\n• Cell Stem Cell"],["成績評量標準","• Participation & Discussion: 30 %\n• Essays: 30 % (15% each)\n• Oral Presentation: 40% (10% each)"],["教學方法",""],["教學目標","Upon successful completion of this course, students will be able to:\n1. Distinguish narrow and broad definitions of tissue engineering and explain their relevance.\n2. Describe biomaterials, scaffolds, and cell–material interactions.\n3. Explain principles of stem cell biology, regenerative signals, and gene-based therapeutic strategies.\n4. Understand the role of the immune system in regeneration and biomaterial integration.\n5. Analyze organ-specific engineering approaches.\n6. Evaluate enabling technologies such as organoids, organ-on-chip platforms, and 3D bioprinting.\n7. Understand translational workflows including GMP, regulatory pathways, and product commercialization.\n8. Integrate multidisciplinary knowledge to generate a regenerative medicine–based solution."]],"office_time":[["劉昭麟","Tue Noon"]],"schedule":[["2026/02/24","5","7","3","劉昭麟","Orientation","","Orientation",""],["2026/03/03","5","7","3","劉昭麟","Foundations of Tissue Engineering","","Definition, Biology of Tissue Repair, Unmet Clinical Needs",""],["2026/03/10","5","7","3","劉昭麟","Elements of Tissue Engineering","","Elements of Tissue Engineering",""],["2026/03/17","5","7","3","劉昭麟","Discussion for Elements of Tissue Engineering","","Discussion for Elements of Tissue Engineering",""],["2026/03/24","5","7","3","劉昭麟","Organ Engineering","","Bone regeneration",""],["2026/03/31","5","7","3","劉昭麟","IVD regeneration","","IVD regeneration",""],["2026/04/07","5","7","3","劉昭麟","Discussion for Bone and IVD regeneration","","Discussion for Bone and IVD regeneration",""],["2026/04/14","5","7","3","劉昭麟","Mid-term evaluation","","essays",""],["2026/04/21","5","7","3","劉昭麟","Regenerative Medicine","","stem cells, MSCs, iPSCs",""],["2026/04/28","5","7","3","劉昭麟","Immune System & Regenerative Immunology","","Immune System & Regenerative Immunology",""],["2026/05/05","5","7","3","劉昭麟","Innovation and Future Direction","","Organoids, Xenotransplantation",""],["2026/05/12","5","7","3","劉昭麟","Discussion for Regenerative Medicine applications","","Discussion for Regenerative Medicine applications",""],["2026/05/19","5","7","3","劉昭麟","Stem Cells, Signals & Gene-Based Approaches (1)","","Cell therapy, Extracellular vesicles, Growth factors",""],["2026/05/26","5","7","3","劉昭麟","Stem Cells, Signals & Gene-Based Approaches (2)","","Gene therapy, CRISPR, gene-modified cell therapy",""],["2026/06/02","5","7","3","劉昭麟","Discussion for Stem Cells, Signals & Gene-Based Approaches","","Discussion for Stem Cells, Signals & Gene-Based Approaches",""],["2026/06/09","5","7","3","劉昭麟","Final term evaluation","","essays",""],["2026/06/16","5","7","3","劉昭麟","Self-study: Translation & Regulatory Science","","GMP-grade, preclinical and clinical trial phases",""],["2026/06/23","5","7","3","劉昭麟","Self-study: Enabling Technologies","","Organ-on-Chip, 3D- & 4D-Bioprinting",""]]}